Amal Al‐Aboudi

541 total citations
19 papers, 414 citations indexed

About

Amal Al‐Aboudi is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Amal Al‐Aboudi has authored 19 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Pharmacology and 4 papers in Organic Chemistry. Recurrent topics in Amal Al‐Aboudi's work include Cholinesterase and Neurodegenerative Diseases (6 papers), Computational Drug Discovery Methods (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Amal Al‐Aboudi is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (6 papers), Computational Drug Discovery Methods (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Amal Al‐Aboudi collaborates with scholars based in Jordan, Pakistan and Sudan. Amal Al‐Aboudi's co-authors include Fatma U. Afifi, Raed A. Al‐Qawasmeh, Taleb H. Al‐Tel, M. Iqbal Choudhary, Atta‐ur Rahman, Syed Ghulam Musharraf, Zaheer Ul‐Haq, Mohammad S. Mubarak, Mustafa M. El‐Abadelah and Masood Parvez and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Current Pharmaceutical Design.

In The Last Decade

Amal Al‐Aboudi

18 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amal Al‐Aboudi Jordan 12 171 132 81 69 64 19 414
Abhijeet S. Kate India 13 199 1.2× 71 0.5× 51 0.6× 104 1.5× 48 0.8× 40 518
Chetna Kharbanda India 13 163 1.0× 316 2.4× 46 0.6× 69 1.0× 38 0.6× 21 492
Yakub Ali India 14 175 1.0× 342 2.6× 46 0.6× 73 1.1× 39 0.6× 23 525
Asnuzilawati Asari Malaysia 14 185 1.1× 219 1.7× 23 0.3× 104 1.5× 31 0.5× 39 537
Benjamin Boucherle France 10 166 1.0× 141 1.1× 37 0.5× 97 1.4× 15 0.2× 23 403
Shiv Vardan Singh India 15 189 1.1× 227 1.7× 46 0.6× 29 0.4× 38 0.6× 23 583
Jae Eun Kang South Korea 7 181 1.1× 129 1.0× 22 0.3× 44 0.6× 59 0.9× 8 376
Mariana Torres‐Piedra Mexico 8 86 0.5× 145 1.1× 31 0.4× 42 0.6× 100 1.6× 8 354
Shaimaa Fayez Egypt 17 221 1.3× 198 1.5× 83 1.0× 129 1.9× 22 0.3× 44 642
Li‐Kang Ho Taiwan 16 263 1.5× 130 1.0× 97 1.2× 126 1.8× 17 0.3× 29 707

Countries citing papers authored by Amal Al‐Aboudi

Since Specialization
Citations

This map shows the geographic impact of Amal Al‐Aboudi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amal Al‐Aboudi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amal Al‐Aboudi more than expected).

Fields of papers citing papers by Amal Al‐Aboudi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amal Al‐Aboudi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amal Al‐Aboudi. The network helps show where Amal Al‐Aboudi may publish in the future.

Co-authorship network of co-authors of Amal Al‐Aboudi

This figure shows the co-authorship network connecting the top 25 collaborators of Amal Al‐Aboudi. A scholar is included among the top collaborators of Amal Al‐Aboudi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amal Al‐Aboudi. Amal Al‐Aboudi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Jamwal, Sumit, et al.. (2019). Therapeutic Potential of Agonists and Antagonists of A1, A2a, A2b and A3 Adenosine Receptors. Current Pharmaceutical Design. 25(26). 2892–2905. 26 indexed citations
4.
Khalil, Enam A., et al.. (2019). Schinus molle L. Collected from Jordan and Turkey: Essential Oil Composition and Anticholinesterase Activity. Journal of Essential Oil Bearing Plants. 22(3). 704–716. 11 indexed citations
5.
Agrawal, Nikhil, Balakumar Chandrasekaran, & Amal Al‐Aboudi. (2019). Recent Advances in the In-silico Structure-based and Ligand-based Approaches for the Design and Discovery of Agonists and Antagonists of A2A Adenosine Receptor. Current Pharmaceutical Design. 25(7). 774–782. 13 indexed citations
6.
Al‐Jaber, Hala I., et al.. (2018). Essential Oil Composition and Anticholinesterase Activity Evaluation of Achillea fragrantissima Growing Wild in Jordan. Journal of Herbs Spices & Medicinal Plants. 24(3). 272–281. 13 indexed citations
7.
Al‐Aboudi, Amal, et al.. (2018). Composition and Antioxidant, Anticholinesterase, and Antibacterial Activities of the Essential Oil of Salvia buchananii from Algeria. Chemistry of Natural Compounds. 54(3). 581–583. 4 indexed citations
9.
Al‐Aboudi, Amal, et al.. (2015). In-silico identification of the binding mode of synthesized adamantyl derivatives inside cholinesterase enzymes. Acta Pharmacologica Sinica. 36(7). 879–886. 14 indexed citations
10.
El‐Abadelah, Mustafa M., et al.. (2014). Synthesis and Antibacterial Activity of Some Novel 4‐Oxopyrido[2,3‐a]phenothiazines. Archiv der Pharmazie. 347(11). 861–872. 6 indexed citations
11.
Al‐Aboudi, Amal, et al.. (2014). Microbial Transformation of (-)-Alloisolongifolene. Oriental Journal Of Chemistry. 30(3). 941–945. 3 indexed citations
12.
Al‐Aboudi, Amal & Fatma U. Afifi. (2010). Plants used for the treatment of diabetes in Jordan: A review of scientific evidence. Pharmaceutical Biology. 49(3). 221–239. 70 indexed citations
13.
Al‐Tel, Taleb H., et al.. (2010). Synthesis and antimicrobial activity of cholic acid hydrazone analogues. European Journal of Medicinal Chemistry. 45(6). 2307–2313. 95 indexed citations
14.
Al‐Aboudi, Amal, et al.. (2009). Biotransformation of methyl cholate by Aspergillus niger. Steroids. 74(4-5). 483–486. 18 indexed citations
15.
Choudhary, M. Iqbal, et al.. (2009). New oxandrolone derivatives by biotransformation using Rhizopus stolonifer. Steroids. 74(13-14). 1040–1044. 29 indexed citations
16.
Al‐Tel, Taleb H., Raed A. Al‐Qawasmeh, Marco F. Schmidt, et al.. (2009). Rational Design and Synthesis of Potent Dibenzazepine Motifs as β-Secretase Inhibitors. Journal of Medicinal Chemistry. 52(20). 6484–6488. 31 indexed citations
17.
Al‐Aboudi, Amal, et al.. (2008). Microbial transformation of testosterone byRhizopus stoloniferandFusarium lini. Natural Product Research. 22(17). 1498–1509. 25 indexed citations
18.
Al‐Aboudi, Amal, Hana M. Odeh, Asaad Khalid, et al.. (2008). Butyrylcholinesterase inhibitory activity of testosterone and some of its metabolites. Journal of Enzyme Inhibition and Medicinal Chemistry. 24(2). 553–558. 6 indexed citations
19.
Lämmler, C., et al.. (1989). Characterization of albumin-binding properties of Peptostreptococcus magnus. Canadian Journal of Microbiology. 35(6). 614–618. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026